| 1 |
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians
Open access |
25 Jan 2016 |
18,026 |
| 2 |
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Hiroshi Maeda, Jun Wu, Tomohiro Sawa et al. · Journal of Controlled Release
|
Mar 2000 |
6,577 |
| 3 |
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al. · Autophagy
Open access2,467 authors |
2 Jan 2016 |
6,023 |
| 4 |
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
Jean‐Charles Soria et al. · New England Journal of Medicine
Open access |
18 Nov 2017 |
5,475 |
| 5 |
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark E. Robson, Seock‐Ah Im, Elżbieta Senkus et al. · New England Journal of Medicine
Open access |
4 Jun 2017 |
3,322 |
| 6 |
First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer
Benjamin J. Solomon, Tony S.K. Mok, Dong‐Wan Kim et al. · New England Journal of Medicine
Open access |
3 Dec 2014 |
3,251 |
| 7 |
Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
Suresh S. Ramalingam et al. · New England Journal of Medicine
Open access |
21 Nov 2019 |
2,933 |
| 8 |
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
James C. Yao, Manisha H. Shah, Tetsuhide Ito et al. · New England Journal of Medicine
Open access |
9 Feb 2011 |
2,877 |
| 9 |
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
Shinichi Sakuramoto, Mitsuru Sasako, Toshiharu Yamaguchi et al. · New England Journal of Medicine
Open access |
31 Oct 2007 |
2,547 |
| 10 |
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke, Kei Muro, Eric Van Cutsem et al. · The Lancet Oncology
|
17 Sep 2014 |
2,505 |
| 11 |
Comprehensive genomic profiles of small cell lung cancer
Julie George et al. · Nature
Open access |
10 Jul 2015 |
2,448 |
| 12 |
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Yoon‐Koo Kang et al. · The Lancet
Open access |
12 Oct 2017 |
2,317 |
| 13 |
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Shanu Modi et al. · New England Journal of Medicine
Open access |
11 Dec 2019 |
2,026 |
| 14 |
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al. · Seminars in Cancer Biology
Open access |
5 Apr 2015 |
1,684 |
| 15 |
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
Kohei Shitara, Yung‐Jue Bang, Satoru Iwasa et al. · New England Journal of Medicine
Open access |
29 May 2020 |
1,352 |
| 16 |
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
Ken Kato, Byoung Chul Cho, Masanobu Takahashi et al. · The Lancet Oncology
Open access |
30 Sep 2019 |
1,262 |
| 17 |
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
Walter John Curran, Rebecca Paulus, Corey Jay Langer et al. · JNCI Journal of the National Cancer Institute
Open access |
8 Sep 2011 |
1,248 |
| 18 |
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012
Kyu‐Won Jung, Young‐Joo Won, Hyun-Joo Kong et al. · Cancer Research and Treatment
Open access |
3 Mar 2015 |
1,167 |
| 19 |
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi et al. · The Lancet
|
3 Jun 2016 |
1,145 |
| 20 |
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Heather A. Wakelee, Moïshe Liberman, Terufumi Kato et al. · New England Journal of Medicine
Open access |
3 Jun 2023 |
1,142 |
| 21 |
TGF-β signaling in health, disease and therapeutics
Ziqin Deng, Tao T. Fan, Xiao Chu et al. · Signal Transduction and Targeted Therapy
Open access |
21 Mar 2024 |
1,141 |
| 22 |
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
Sung Hoon Noh, Sook Ryun Park, Han‐Kwang Yang et al. · The Lancet Oncology
Open access |
15 Oct 2014 |
1,090 |
| 23 |
Brain metastases
Achal Singh Achrol, Robert Charles Rennert, Carey K. Anders et al. · Nature Reviews Disease Primers
Review |
17 Jan 2019 |
1,069 |
| 24 |
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
Seock‐Ah Im, Yen‐Shen Lu, Aditya Bardia et al. · New England Journal of Medicine
Open access |
4 Jun 2019 |
1,044 |
| 25 |
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
Mitsuru Sasako, Takeshi Sano, Seiichiro Yamamoto et al. · New England Journal of Medicine
Open access |
30 Jul 2008 |
1,029 |
| 26 |
Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial
Seung‐Yong Jeong et al. · The Lancet Oncology
|
15 May 2014 |
906 |
| 27 |
Identification of Genes Upregulated in ALK -Positive and EGFR/KRAS/ALK -Negative Lung Adenocarcinomas
Hirokazu Okayama et al. · Cancer Research
Open access |
12 Nov 2011 |
906 |
| 28 |
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
Alexander Edward Dela Cruz Drilon et al. · New England Journal of Medicine
Open access |
26 Aug 2020 |
856 |
| 29 |
Cuproptosis: mechanisms and links with cancers
Jiaming Xie, Yannan Yang, Yibo Gao et al. · Molecular Cancer
Open access |
7 Mar 2023 |
821 |
| 30 |
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
Yuanyuan Zhang, Hongyan Chen, Hongnan Mo et al. · Cancer Cell
Open access |
15 Oct 2021 |
818 |
| 31 |
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Yoon‐Koo Kang et al. · The Lancet Oncology
Open access |
11 Jan 2022 |
808 |
| 32 |
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Philip James Johnson et al. · Journal of Clinical Oncology
|
27 Aug 2013 |
780 |
| 33 |
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Jung Sub Lim, Michele Mietus‐Snyder, Annie Valente et al. · Nature Reviews Gastroenterology & Hepatology
Review |
6 Apr 2010 |
778 |
| 34 |
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
Takuji Okusaka, Kohei Nakachi, Akira Fukutomi et al. · British Journal of Cancer
Open access |
13 Jul 2010 |
757 |
| 35 |
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
Masatoshi Kudo et al. · Gut
Open access |
4 Dec 2019 |
739 |
| 36 |
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
Tatsuhiro Shibata, Tsutomu Ohta, Kit I. Tong et al. · Proceedings of the National Academy of Sciences
Open access |
29 Aug 2008 |
733 |
| 37 |
Surgery Plus Chemotherapy Compared With Surgery Alone for Localized Squamous Cell Carcinoma of the Thoracic Esophagus: A Japan Clinical Oncology Group Study—JCOG9204
Nobutoshi Ando, Toshifumi Iizuka, Hiroko Ide et al. · Journal of Clinical Oncology
|
12 Dec 2003 |
731 |
| 38 |
Endoscopic submucosal dissection of early gastric cancer
Takuji Gotoda, Hironori Yamamoto, Roy M. Soetikno · Journal of Gastroenterology
|
Oct 2006 |
699 |
| 39 |
Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501
Takeshi Sano, Mitsuru Sasako, Seiichiro Yamamoto et al. · Journal of Clinical Oncology
|
17 Jun 2004 |
679 |
| 40 |
Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish
Takashi Sügimura, Keiji Wakabayashi, Hitoshi Nakagama et al. · Cancer Science
Open access |
Apr 2004 |
673 |
| 41 |
A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)
Kenji Suzuki, Teruaki Koike, T. Asakawa et al. · Journal of Thoracic Oncology
Open access |
18 Feb 2011 |
664 |
| 42 |
Integrative Proteomic Characterization of Human Lung Adenocarcinoma
Jun‐Yu Xu et al. · Cell
Open access |
Jul 2020 |
658 |
| 43 |
Cancer survival in C hina, 2003–2005: A population‐based study
Hongmei Zeng et al. · International Journal of Cancer
Open access |
20 Sep 2014 |
644 |
| 44 |
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
Yuichiro Ohe, Yasuo Ohashi, Kaoru Kubota et al. · Annals of Oncology
Open access |
2 Nov 2006 |
638 |
| 45 |
Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project
Megumi Hori, Tomohiro Matsuda, Akiko Shibata et al. · Japanese Journal of Clinical Oncology
|
3 Jul 2015 |
626 |
| 46 |
Improved Quality of Life Outcomes After Laparoscopy-Assisted Distal Gastrectomy for Early Gastric Cancer
Young‐Woo Kim, Yong Hae Baik, Young Ho Yun et al. · Annals of Surgery
|
21 Oct 2008 |
609 |
| 47 |
Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen
Yusuke Yoshioka, Nobuyoshi Kosaka, Yuki Konishi et al. · Nature Communications
Open access |
7 Apr 2014 |
607 |
| 48 |
Estimates of human fertility and pregnancy loss
Michael J. Zinaman, E. D. Clegg, Charles Brown et al. · Fertility and Sterility
Open access |
Mar 1996 |
591 |
| 49 |
Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality
Jae Kwan Jun, Kui Son Choi, Hooyeon Lee et al. · Gastroenterology
Open access |
29 Jan 2017 |
578 |
| 50 |
Cancer Incidence and Incidence Rates in Japan in 2008: A Study of 25 Population-based Cancer Registries for the Monitoring of Cancer Incidence in Japan (MCIJ) Project
Ayako Matsuda, Tomohiro Matsuda, Akiko Shibata et al. · Japanese Journal of Clinical Oncology
|
5 Feb 2014 |
574 |